BioAtla (BCAB) Share-based Compensation (2020 - 2026)
BioAtla (BCAB) reported Share-based Compensation of $619,000 for Q2 2026, down 55.0% from $1.38 million a year earlier and down 35.3% from the prior quarter.
BioAtla (BCAB) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioAtla's Share-based Compensation came in at $3.99 million, down 44.2% year-over-year; for FY2025, it came in at $5.43 million, down 39.1% from FY2024.
- Share-based Compensation has declined for four consecutive years.
- By year, Share-based Compensation came in at $8.92 million in FY2024 (-34.1%), $13.54 million in FY2023 (-7.0%), $14.56 million in FY2022 (-42.0%) and $25.12 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q4 2020.
- Year over year, Share-based Compensation has now declined in each of the last 18 quarters, with an average decline of 40.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Share-based Compensation ranged from 0.5% (Q1 2023) to 68.8% (Q2 2022).
- Per Business Quant data, the three quarters before Q2 2026 came in at $956,000 (Q1 2026), $1.12 million (Q4 2025) and $1.29 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | BioAtla | 2.99 Mn | -15.95 Mn | - | 619,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 619,000.00 |
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 3.61 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 4.37 Mn |
BioAtla Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();